Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

COVID19 (SARS-CoV2) vaccination/vaccine

5

X.m Vascultis (pulmonary, extrathoracic or systemic)-ANCA status unknown or negative)

1
Last update : 14/07/2021
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine.
Internal and emergency medicine 2022 Jun;17;1239-1241 2022 Jun
Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitis.
Journal of cosmetic dermatology 2022 Jan;21;51-53 2022 Jan
Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine.
Kidney international 2021 Sep;100;706-707 2021 Sep

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies